| pubmed-article:17898482 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17898482 | lifeskim:mentions | umls-concept:C0444626 | lld:lifeskim |
| pubmed-article:17898482 | lifeskim:mentions | umls-concept:C0444669 | lld:lifeskim |
| pubmed-article:17898482 | lifeskim:mentions | umls-concept:C0302603 | lld:lifeskim |
| pubmed-article:17898482 | lifeskim:mentions | umls-concept:C0871161 | lld:lifeskim |
| pubmed-article:17898482 | lifeskim:mentions | umls-concept:C0233929 | lld:lifeskim |
| pubmed-article:17898482 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17898482 | pubmed:dateCreated | 2007-9-27 | lld:pubmed |
| pubmed-article:17898482 | pubmed:abstractText | Cholesteryl 4-(7-diethylamino-2-oxo-2H-1-benzopyran-3-yl)benzoate (1) had an enantiotropic cholesteric phase. The crystal structure of 1 has been determined by X-ray crystallographic analysis. The crystals of 1 had intermolecular CH...pi and CH...O interactions. 7-(Diethylamino)-3-phenylcoumarin derivatives (1) gave a strong emission band at 500 nm in the solid state when excited at 440 nm. | lld:pubmed |
| pubmed-article:17898482 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17898482 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17898482 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17898482 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17898482 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17898482 | pubmed:issn | 1347-3352 | lld:pubmed |
| pubmed-article:17898482 | pubmed:author | pubmed-author:TakahashiHaji... | lld:pubmed |
| pubmed-article:17898482 | pubmed:author | pubmed-author:MatsumotoTais... | lld:pubmed |
| pubmed-article:17898482 | pubmed:author | pubmed-author:KuboKanjiK | lld:pubmed |
| pubmed-article:17898482 | pubmed:author | pubmed-author:TakechiHaruko... | lld:pubmed |
| pubmed-article:17898482 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17898482 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:17898482 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17898482 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17898482 | pubmed:pagination | 195-200 | lld:pubmed |
| pubmed-article:17898482 | pubmed:dateRevised | 2009-8-11 | lld:pubmed |
| pubmed-article:17898482 | pubmed:meshHeading | pubmed-meshheading:17898482... | lld:pubmed |
| pubmed-article:17898482 | pubmed:meshHeading | pubmed-meshheading:17898482... | lld:pubmed |
| pubmed-article:17898482 | pubmed:meshHeading | pubmed-meshheading:17898482... | lld:pubmed |
| pubmed-article:17898482 | pubmed:meshHeading | pubmed-meshheading:17898482... | lld:pubmed |
| pubmed-article:17898482 | pubmed:meshHeading | pubmed-meshheading:17898482... | lld:pubmed |
| pubmed-article:17898482 | pubmed:meshHeading | pubmed-meshheading:17898482... | lld:pubmed |
| pubmed-article:17898482 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17898482 | pubmed:articleTitle | Crystal structure, mesomorphic and emission properties of liquid crystals having a 7-(diethylamino)-3-phenylcoumarin core. | lld:pubmed |
| pubmed-article:17898482 | pubmed:affiliation | Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Hokkaido, Japan. | lld:pubmed |
| pubmed-article:17898482 | pubmed:publicationType | Journal Article | lld:pubmed |
